FDA permits marketing of AI software that autonomously detects diabetic retinopathy
Mobi Health News
APRIL 12, 2018
The FDA has granted diagnostics company IDx’s De Novo request to market its AI-based software system for the autonomous detection of diabetic retinopathy in adults who have diabetes, called IDx-DR.
Let's personalize your content